Bioxytran, Inc. (OTCMKTS:BIXT) Sees Significant Increase in Short Interest

Bioxytran, Inc. (OTCMKTS:BIXTGet Free Report) was the target of a significant increase in short interest in the month of July. As of July 15th, there was short interest totalling 11,500 shares, an increase of 26.4% from the June 30th total of 9,100 shares. Based on an average daily volume of 181,200 shares, the short-interest ratio is presently 0.1 days.

Bioxytran Trading Down 4.0 %

Shares of OTCMKTS BIXT traded down $0.01 during midday trading on Friday, hitting $0.12. The company’s stock had a trading volume of 6,459 shares, compared to its average volume of 90,862. The business’s 50 day moving average is $0.11 and its two-hundred day moving average is $0.12. Bioxytran has a 12-month low of $0.07 and a 12-month high of $0.35.

About Bioxytran

(Get Free Report)

Bioxytran, Inc, a clinical stage pharmaceutical company, focuses on the development, manufacture, and commercialization of therapeutic drugs to address hypoxia in humans. The company's lead drug candidate is BXT-25, an oxygen-carrying small molecule consisting of bovine hemoglobin stabilized with a co-polymer for use in the treatment of hypoxic conditions in the brain resulting from stroke, and hypoxic conditions in wounds to prevent necrosis and to promote healing.

Recommended Stories

Receive News & Ratings for Bioxytran Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bioxytran and related companies with MarketBeat.com's FREE daily email newsletter.